DXCM News and Press, DexCom Inc. From 10/23/22

Summary Baxter International has had a rough year or so, with shares declining far more than the market has. Some of this was justified by the company's high share price and weakening fundamentals. But given where shares are today, the firm does seem to offer some upside for i...

If you're investing in the stock market right now, you know how challenging an environment it's been for investors of all trading styles lately. Whether you gravitate toward growth-oriented stocks, value stocks, or a mixture of both, few companies have been spared the volatility hitting the...

This bear market may not exactly put you in the mood for investing. But now is actually a great time to scoop up shares of solid companies. Why? Because many are trading at a discount. Yet their long-term outlooks remain bright. This is the case for DexCom (NASDAQ: DXCM) . The c...

FinancialBuzz.com News Commentary New York, NY (10/13/2022) – The medical device industry is growing steadily thanks to new technologies as well as an emerging medical infrastructure around the world. Some of the fastest growing segments in the medical device market by applicatio...

Diabetes has been on the rise for a while because of both the aging of the U.S. population -- as well as expanding waistlines. According to the National Diabetes Statistics Report, 37.3 million people in the United States have diabetes, and 96 million in the U.S. have pre-diabetes, includin...

Shares of DexCom (NASDAQ: DXCM) surged higher on Friday, rising as much as 10.6%. At the end of the trading day, the stock was still up 7.3%, even as the broader market indexes crumbled. The catalyst that sent the medical device maker higher was a pending decision by Medicar...

DexCom ( NASDAQ: DXCM ) shares jumped ~10% in the pre-market trading Friday after the Centers for Medicare and Medicaid Services (SMC) issued a proposed local coverage determination related to continuous glucose monitoring devices. Wall Street analysts covering the maker...

Investing in equities during a downturn can be challenging. Not every beaten-down stock is worth investing in, and investors must spend time separating the wheat from the chaff. But the benefits can be enormous for those who pick the right companies. A bull market will come eventually, and ...

There's nothing like a strategic product rollout to push the price of a stock higher. This was the case with medical device maker DexCom (NASDAQ: DXCM) , which on news of international expansion saw its share price zoom more than 7% higher on Tuesday. That trounced even the robust 3...

DexCom ( NASDAQ: DXCM ) said its Dexcom G7 Continuous Glucose Monitoring (CGM) system was now available for people with diabetes age two years and older in the U.K., Ireland, Germany, Austria and Hong Kong. The company is also working to launch G7 in New Zeal...